Who are the key players in North America Single Cell Analysis Market industry?

The top five players in the North America Single Cell Analysis Market are Becton, Dickinson and Company (BD), Thermo Fisher Scientific, Illumina, 10x Genomics, and Bio-Rad Laboratories. These companies offer cutting-edge products such as sequencing platforms, reagents, and analytical tools driving innovation in single cell analysis research.

What is the North America Single Cell Analysis Market growth?

The North America Single Cell Analysis Market has witnessed significant growth, driven primarily by advancements in genomic technologies. In 2023, 10x Genomics reported rapid adoption of its Chromium platform, contributing to a market CAGR of over 15%. Increasing investments in precision medicine further boost growth prospects.

Which segment accounted for the largest North America Single Cell Analysis Market share?

The oncology segment held the largest share in the North America Single Cell Analysis Market. Single cell sequencing applications enable early cancer detection, tumor heterogeneity studies, and personalized treatment strategies. Companies like Illumina and Thermo Fisher have developed specialized workflows for oncology research, propelling this segment’s dominance.

What are the factors driving the North America Single Cell Analysis Market?

Key drivers include the increasing prevalence of chronic diseases, technological advancements in sequencing platforms, and rising research funding. For example, Bio-Rad Laboratories’ launch of innovative single cell RNA sequencing kits enhances data accuracy, fueling demand from research institutions and pharmaceutical companies pursuing biomarker discovery.

Which type accounted for the largest North America Single Cell Analysis Market share?

Consumables represented the largest share of the single cell analysis market by type. Reagents, assays, and microfluidic chips provided by leading players like BD and Thermo Fisher Scientific are essential for high-throughput single cell genomics and proteomics experiments, driving recurring revenues within the segment.

Home Healthcare

North America Single Cell Analysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Single Cell Analysis Market Report
Creator: Bussiness Insights
Published: 31-07-2025
License: https://bussinessinsights.com/privacy-policy
Keywords: Healthcare

North America Single Cell Analysis Market: by Type (Flow Cytometry, Next Generation Sequencing, PCR, Microscopy, Mass Spectrometry, Others), Application (Cancer, Neurology, Immunology, Stem Cell, Non-invasive Prenatal Diagnosis, Others), Distribution Channels (Direct Tenders, Third Party Distributors, Retail Sales, E-commerce, Others), Technology (Consumables, Instruments, Software, Services, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20388 | Author: Lily

RD TOC Segmentation Research Methodology Request For Free Sample

North America Single Cell Analysis Market Forecast (2020-2035)

The North America Single Cell Analysis Market is experiencing robust growth, propelled by advancements in genomics, higher prevalence of chronic diseases, and increased funding for life sciences research. With a surge in demand for personalized medicine and ongoing technological innovations in tools like flow cytometry and next-generation sequencing, the market is set to expand at a compelling pace through 2035, reflecting shifting priorities in oncology, neurology, and immunology research.

Latest Market Dynamics

Key Drivers

Rising Investments in Genomics and Life Sciences: In 2025, major funding initiatives by organizations such as the NIH continue to drive the adoption of single cell analysis. Companies like 10x Genomics exemplify commercial progress with their Chromium system, facilitating precise cell-by-cell profiling.

Integration of AI with Single Cell Analytics: Recent launches by companies such as Bio-Rad Laboratories highlight the adoption of artificial intelligence to streamline cell data analysis, enhancing accuracy and reducing turnaround times.
Miniaturization and Automation: The trend towards compact and automated instruments is driven by user demand for efficient laboratory workflows. Thermo Fisher Scientific introduced new benchtop solutions in early 2024 for high-throughput single cell processing.

Expansion of Clinical Applications: The emergence of single cell technologies in prenatal, immunological, and stem cell diagnostics is opening significant clinical opportunities. Beckman Coulter Inc., for example, has expanded its instrument portfolio to meet prenatal diagnostic needs.
Strategic Collaborations: Firms are increasingly partnering with biopharma companies and academic institutions to accelerate development. In June 2024, a joint research endeavor between NanoString Technologies and a leading North American cancer center was announced for advanced tumor profiling.

High Cost and Technical Complexity: Despite its benefits, single cell analysis remains cost-prohibitive for smaller labs and organizations. Smaller biotech firms like Standard BioTools struggle to balance innovation with affordability.
Data Management Bottlenecks: The explosion of high-content data challenges existing digital infrastructures. Fluidigm Corporation introduced cloud-compatible storage in mid-2024 to address data scalability, but widespread adoption continues to be a hurdle.

Regulatory Hurdles: Stringent regulatory approvals for new diagnostic platforms can delay market entry. Takara Bio Inc. recently encountered slower than expected FDA review for its latest single cell product.
Limited Access in Resource-Constrained Settings: Access to advanced single cell technologies remains limited outside major research and clinical hubs. Smaller hospitals and rural life sciences centers face adoption challenges, as highlighted in Merck KGaA’s 2025 customer survey.

The market by type in 2025 is led by Flow Cytometry, which dominates due to its widespread applications in cell sorting and immunophenotyping. Next Generation Sequencing follows, owing to its growing utility in genomic profiling at the single-cell level. PCR-based methods also maintain a strong presence, particularly in clinical and diagnostic settings, reflecting ongoing innovation and accessibility.

By application, Cancer research remains the dominant segment, accounting for more than a third of the market in 2025. Advances in tumor profiling and liquid biopsy technologies drive this growth. Immunology holds the next largest share, reflecting increased need for immune cell profiling in research and clinical diagnostics. Neurology is also gaining ground as single cell analysis unveils novel insights into complex brain disorders.

Market revenue for single cell analysis in North America has witnessed consistent expansion from 2020, reaching a significant milestone in 2025. The compound annual growth rate is projected to remain strong, with revenue surpassing 2,450 Million USD in 2025. This upward trajectory is driven by technology adoption, R&D investments, and expanding clinical applications, forecasting robust gains through 2035.

The United States clearly leads the North American market in 2025, claiming almost three-quarters of the total share, driven by its unmatched bio-research ecosystem and funding infrastructure. Canada follows, benefiting from strong research universities but facing smaller scale. Mexico represents a growing but moderate segment, gaining from expanded healthcare access and emerging industry partnerships.

Academic research institutions make up the largest category of buyers in North America, responsible for nearly half the market in 2025. Pharmaceutical and biotechnology companies account for almost a third as they ramp up drug discovery and biomarker identification using single-cell technologies. Contract research organizations and hospitals are emerging buyers as clinical adoption broadens.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2450
Regions	United States, Canada, Mexico
Segments	By Type, By Application, By Distribution Channels, By Technology, By Organization Size
Players	Thermo Fisher Scientific, Becton Dickinson (BD), Fluidigm Corporation, Bio-Rad Laboratories Inc., Illumina Inc., QIAGEN N.V., Beckman Coulter Inc., Agilent Technologies Inc., 10x Genomics, Merck KGaA, Promega Corporation, Takara Bio Inc., Standard BioTools Inc. (Fluidigm), NanoString Technologies Inc., Oxford Nanopore Technologies

June 12, 2024: Thermo Fisher Scientific launched a new microfluidics-based single cell analyzer for rapid genomics and proteomics applications.
July 8, 2024: 10x Genomics unveiled the Chromium X Expansion Kit, accelerating multi-omic single cell workflows for cancer research.
August 2, 2024: NanoString Technologies announced a strategic collaboration with the Dana-Farber Cancer Institute to leverage single cell platforms in immuno-oncology studies.
August 15, 2024: Illumina Inc. upgraded its sequencing system for higher throughput in clinical diagnostics, targeting single cell and rare cell populations.
September 10, 2024: BD introduced a cloud-enabled software suite for automated data analysis across its single-cell instrumentation portfolio.

About the Author

Lily

Senior Market Research Analyst

Lily is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Lily brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lily has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Single Cell Analysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Single Cell Analysis Market Forecast (2020-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Single Cell Analysis Market Share by Type (2025)

North America Single Cell Analysis Market Share by Applications (2025)

North America Single Cell Analysis Market Revenue, 2020-2035

North America Single Cell Analysis Market YOY Growth, 2020-2035

North America Single Cell Analysis Market by Region (% Share, 2025)

Market Share by Key Players (2025)

Market Share by Buyer Segment (2025)

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author